Clinical Scorecard: Deficiency of Deoxyguanosine Kinase Links Purine Metabolism to Activation of Innate Immunity and Lipid Accumulation in Liver Cells

At a Glance

Key Highlights

• DGUOK deficiency leads to increased lipid droplet accumulation and type I interferon activation.
• Preserved mtDNA content does not prevent hepatic steatosis and inflammation.
• Acute DGUOK depletion causes global DNA hypomethylation and activation of interferon-stimulated genes.
• Purine imbalance is linked to metabolic reprogramming and innate immune signaling.
• DGUOK's role extends beyond mtDNA maintenance to include lipid homeostasis.

Guideline-Based Recommendations

Diagnosis

• Assess for DGUOK mutations in patients with MDS symptoms.

Management

• Monitor liver function and metabolic status in patients with DGUOK deficiency.

Monitoring & Follow-up

• Evaluate lipid accumulation and inflammatory markers in affected individuals.

Risks

• Risk of liver failure and systemic disease recurrence post-liver transplantation.

Patient & Prescribing Data

Infants and children with DGUOK deficiency presenting with cholestasis and hepatic steatosis.

No disease-modifying therapies currently exist; understanding DGUOK functions is critical for future treatment development.

Clinical Best Practices

• Conduct thorough metabolic and immunologic assessments in patients with suspected DGUOK deficiency.
• Consider genetic counseling for families affected by DGUOK deficiency.

Related Resources & Content

• Mitochondrial DNA Depletion Syndromes Overview
• Role of DGUOK in Purine Metabolism